Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.12 USD | -4.00% | +4.00% | +9.86% |
May. 09 | Transcript : DiaMedica Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024 | |
Apr. 17 | DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 162M 118M |
---|---|---|---|---|---|
Net income 2024 * | -36M -26.31M | Net income 2025 * | -47M -34.35M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.8
x | P/E ratio 2025 * |
-3.74
x | Employees | 19 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.96% |
Latest transcript on DiaMedica Therapeutics Inc.
1 day | -4.00% | ||
1 week | +4.00% | ||
Current month | +23.32% | ||
1 month | +17.74% | ||
3 months | -3.41% | ||
6 months | +32.20% | ||
Current year | +9.86% |
Managers | Title | Age | Since |
---|---|---|---|
Rick Pauls
CEO | Chief Executive Officer | 52 | 05-03-31 |
Scott Kellen
DFI | Director of Finance/CFO | 59 | 18-03-31 |
Ambarish Shah
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Kuntz
BRD | Director/Board Member | 66 | 23-05-29 |
Tanya Lewis
BRD | Director/Board Member | 53 | 23-02-28 |
James Parsons
BRD | Director/Board Member | 58 | 10-10-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 3.12 | -4.00% | 22,577 |
24-05-09 | 3.25 | -6.34% | 74,346 |
24-05-08 | 3.47 | -5.19% | 102,314 |
24-05-07 | 3.66 | +4.57% | 142,832 |
24-05-06 | 3.5 | +16.67% | 143,897 |
Delayed Quote Nasdaq, May 10, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.86% | 118M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- DMAC Stock